These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7642308)

  • 1. Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats.
    Gaede KI; Baumeister E; Heesemann J
    Infect Immun; 1995 Sep; 63(9):3697-701. PubMed ID: 7642308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of arthritis in Lewis rats by a monoclonal antibody against alpha beta T cell receptor: differential sensitivity of Yersinia-induced arthritis versus adjuvant arthritis.
    Gaede K; Nazet M; Bosse D; Hünig ; Heesemann J
    Clin Immunol Immunopathol; 1995 Dec; 77(3):339-48. PubMed ID: 7586745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi.
    Schmitz JL; Lovrich SD; Callister SM; Schell RF
    Infect Immun; 1991 Oct; 59(10):3815-8. PubMed ID: 1894378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
    Heesemann J; Gaede K; Autenrieth IB
    APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cobra venom factor abrogates passive humoral resistance to syphilitic infection in hamsters.
    Azadegan AA; Tabor DR; Schell RF; LeFrock JL
    Infect Immun; 1984 Jun; 44(3):740-2. PubMed ID: 6724696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica.
    Hanski C; Naumann M; Grützkau A; Pluschke G; Friedrich B; Hahn H; Riecken EO
    Infect Immun; 1991 Mar; 59(3):1106-11. PubMed ID: 1997413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia-associated arthritis in rats: effect of 65 kDa heat shock protein, bovine serum albumin and incomplete Freund's adjuvant.
    Gripenberg-Lerche C; Toivanen A; Toivanen P
    Clin Exp Rheumatol; 1995; 13(3):321-5. PubMed ID: 7554558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Yersinia enterocolitica infection in rats: analysis of the immune response to plasmid-encoded antigens of arthritis-susceptible Lewis rats and arthritis-resistant Fischer rats.
    Gaede K; Mack D; Heesemann J
    Med Microbiol Immunol; 1992; 181(3):165-72. PubMed ID: 1522826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats.
    Gaede KI; Heesemann J
    Infect Immun; 1995 Feb; 63(2):714-9. PubMed ID: 7822048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on type II collagen induced polyarthritis in rats. Effect of complement depletion.
    Kerwar SS; Bauman N; Oronsky AL; Sloboda AE
    J Immunopharmacol; 1981-1982; 3(3-4):323-37. PubMed ID: 7347767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.
    Oberholzer J; Yu D; Triponez F; Cretin N; Andereggen E; Mentha G; White D; Buehler L; Morel P; Lou J
    Immunology; 1999 May; 97(1):173-80. PubMed ID: 10447729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in cobra venoms affecting the complement system.
    Vogt W
    Toxicon; 1982; 20(1):299-303. PubMed ID: 7080043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia-associated arthritis in the rat: experimental model for human reactive arthritis?
    Toivanen A; Merilahti-Palo R; Gripenberg C; Lahesmaa-Rantala R; Söderström KO; Jaakkola UM
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):261-9. PubMed ID: 3495095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cobra venom factor treatment on latent feline leukemia virus infection.
    Kraut EH; Rojko JL; Olsen RG; Tuomari DL
    J Virol; 1985 Jun; 54(3):873-5. PubMed ID: 2987539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the pathogenesis of Yersinia infections.
    Heesemann J; Gaede K
    Rheumatol Int; 1989; 9(3-5):213-7. PubMed ID: 2692128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Yersinia enterocolitica and pseudotuberculosis reactive arthritis with antinuclear antibodies. 4 cases].
    Treves R; Arnaud M; Jacob P; Burki F; Desproges-Gotteron R
    Sem Hop; 1983 Jan; 59(2):122-3. PubMed ID: 6301030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in Yersinia arthritis.
    Repo H; Meri S; Leirisalo-Repo M
    Contrib Microbiol Immunol; 1987; 9():141-4. PubMed ID: 3499289
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of complement in the expression of delayed-type hypersensitivity in rats: studies with cobra venom factor.
    Jungi TW; McGregor DD
    Infect Immun; 1979 Mar; 23(3):633-43. PubMed ID: 313366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection.
    Hill JL; Yu DT
    Infect Immun; 1987 Mar; 55(3):721-6. PubMed ID: 3493220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model.
    Zhang Y; Gripenberg-Lerche C; Söderström KO; Toivanen A; Toivanen P
    Arthritis Rheum; 1996 Jul; 39(7):1238-43. PubMed ID: 8670337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.